Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Stroke: New approach to treatment

06.02.2015

The inhibition of an inflammatory protein drastically reduces consequential damage following a stroke. This has now been demonstrated by scientists from the University of Würzburg. Their discovery could significantly improve the treatment provided to stroke patients.

Blood vessels that supply the brain with vital oxygen are suddenly blocked by blood clots; this causes nerve cells to die, and the sufferer develops symptoms that include paralysis and speech disorders: this is the typical scenario for a stroke.

At this point, rapid action is needed: The sooner the blood clots are dissolved with medication, the less severe the consequential damage is for the sufferer as a rule. Yet, often patients reach a life-saving hospital too late. This delay is also one reason why the risk of dying from a stroke in Germany is around ten times higher than the danger of being injured in a traffic accident.

Excess pressure inside the skull

However, this lack of oxygen inside the brain is only one issue among many that can occur with a stroke. One dreaded side effect, for example, are inflammatory processes in the brain and water retention in the nervous tissue, which is known as cerebral edema formation. Since the brain is surrounded by a rigid cranial bone, excess pressure builds up inside the skull, initially affecting healthy brain tissue at the same time.

“There are many facets to a stroke. It is this that makes it so difficult to treat; after all, most drugs can only target one key area,” says Professor Christoph Kleinschnitz, head of the Stroke Unit at the University of Würzburg’s Department of Neurology.

Publication in the “Annals of Neurology”

This shortage of effective medications might very soon be a thing of the past, hopes the neurologist. Kleinschnitz and his team have succeeded in inhibiting a specific inflammatory protein and, in so doing, noticeably reducing the consequences of a stroke.

They were supported in this by the Würzburg biomedical scientist Professor Bernhard Nieswandt and neurologists from the University of Münster. The researchers present the results of their work in the online issue of the “Annals of Neurology”, the official journal of the American Neurological Association.

“It has been known for quite some time that the inflammatory protein plasma kallikrein damages the nervous tissue in several ways after a stroke,” explains Kleinschnitz. For instance, this protein contributes to the creation of further blood clots in the brain. It also intensifies the inflammation as well as cerebral edema.

So, as a first step, the scientists worked with mice that lacked the gene for plasma kallikrein. These animals developed dramatically smaller strokes and revealed fewer neurological deficiencies. “This observation was very promising but it initially had no relevance to usage on patients. We therefore had to find a way of inhibiting plasma kallikrein pharmacologically as well,” explains Dr. Eva Göb, a research associate on Kleinschnitz’s team.

Antibody is effective even hours later

For this reason, the Würzburg researchers used an antibody that annuls the effect of plasma kallikrein in the blood of the mice. As they were able to show, this method also mitigated the consequences of a stroke dramatically. “What is interesting here is that the antibody itself was still effective when it was injected into the animals with a delay of three hours after the onset of the stroke. This means that the antibody could possibly be used on stroke patients who are late arriving at a hospital,” says Kleinschnitz. However, further studies and a safety test need to be conducted first before that point is reached.

The work in Würzburg Collaborative Research Center (SFB) 688 was funded by the German Research Foundation (DFG).

“Blocking of plasma kallikrein ameliorates stroke by reducing thromboinflammation” Eva Göb, Stephan Reymann, Friederike Langhauser, Michael K. Schuhmann, Peter Kraft, Ina Thielmann, Kerstin Göbel, Marc Brede, György Homola, László Solymosi, Guido Stoll, Christian Geis, Sven G. Meuth, Bernhard Nieswandt, Christoph Kleinschnitz. Annals of Neurology. Published online on January 27, 2015. doi: 10.1002/ana.24380.

Contact

Prof. Dr. Christoph Kleinschnitz, Department of Neurology at the University of Würzburg, T +49 (0)931 201-23756, christoph.kleinschnitz@uni-wuerzburg.de

Gunnar Bartsch | Julius-Maximilians-Universität Würzburg
Further information:
http://www.uni-wuerzburg.de

More articles from Life Sciences:

nachricht Newly designed molecule binds nitrogen
23.02.2018 | Julius-Maximilians-Universität Würzburg

nachricht Atomic Design by Water
23.02.2018 | Max-Planck-Institut für Eisenforschung GmbH

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Attoseconds break into atomic interior

A newly developed laser technology has enabled physicists in the Laboratory for Attosecond Physics (jointly run by LMU Munich and the Max Planck Institute of Quantum Optics) to generate attosecond bursts of high-energy photons of unprecedented intensity. This has made it possible to observe the interaction of multiple photons in a single such pulse with electrons in the inner orbital shell of an atom.

In order to observe the ultrafast electron motion in the inner shells of atoms with short light pulses, the pulses must not only be ultrashort, but very...

Im Focus: Good vibrations feel the force

A group of researchers led by Andrea Cavalleri at the Max Planck Institute for Structure and Dynamics of Matter (MPSD) in Hamburg has demonstrated a new method enabling precise measurements of the interatomic forces that hold crystalline solids together. The paper Probing the Interatomic Potential of Solids by Strong-Field Nonlinear Phononics, published online in Nature, explains how a terahertz-frequency laser pulse can drive very large deformations of the crystal.

By measuring the highly unusual atomic trajectories under extreme electromagnetic transients, the MPSD group could reconstruct how rigid the atomic bonds are...

Im Focus: Developing reliable quantum computers

International research team makes important step on the path to solving certification problems

Quantum computers may one day solve algorithmic problems which even the biggest supercomputers today can’t manage. But how do you test a quantum computer to...

Im Focus: In best circles: First integrated circuit from self-assembled polymer

For the first time, a team of researchers at the Max-Planck Institute (MPI) for Polymer Research in Mainz, Germany, has succeeded in making an integrated circuit (IC) from just a monolayer of a semiconducting polymer via a bottom-up, self-assembly approach.

In the self-assembly process, the semiconducting polymer arranges itself into an ordered monolayer in a transistor. The transistors are binary switches used...

Im Focus: Demonstration of a single molecule piezoelectric effect

Breakthrough provides a new concept of the design of molecular motors, sensors and electricity generators at nanoscale

Researchers from the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague), Institute of Physics of the CAS (IP CAS) and Palacký University...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

2nd International Conference on High Temperature Shape Memory Alloys (HTSMAs)

15.02.2018 | Event News

Aachen DC Grid Summit 2018

13.02.2018 | Event News

How Global Climate Policy Can Learn from the Energy Transition

12.02.2018 | Event News

 
Latest News

Basque researchers turn light upside down

23.02.2018 | Physics and Astronomy

Finnish research group discovers a new immune system regulator

23.02.2018 | Health and Medicine

Attoseconds break into atomic interior

23.02.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>